<p><b>A.</b> Mutation detection in the exons 9 and 20 of PIK3CA from NSCLC. The negative derivative of the fluorescence (−dF/dT) versus temperature graph shows peaks with different Tm. The wild type sample showed a single Tm at 66°C. The heterozygous mutant sample showed an additional peak at 57°C. <b>B.</b> Point mutation in the PI3KCA gene involving a GAG→AAG transition in codon 545 of exon 9 inducing the substitution of a glutammic acid with a lysine (E545K). <b>C.</b> Point mutations in the KRAS gene involving a GGT→GCT, GGT→TGT, GGT→GTT; GGC→TGC transition in codon 12 of exon 2 inducing the substitution of a glycine by an alanine, a cysteine and a valine (G12A G12C G12V) transition in codon 13 of exon 2 inducing the substitution of a g...
Selection of NSCLC patients for targeted therapy is currently based upon the presence of sensitizing...
<p>Dataset A, n = 22/58 (38.5%) AUC = 0.67, 95%CI: 0.5–0.8, p = 0.04), <b>B.</b> Dataset B n = 6/23 ...
Aims To evaluate the incidence of PI3KCA, KRAS and BRAF mutations in primary ovarian clear cell carc...
<p>A. Detection of mutations in PIK3CA by LightCycler (left) and direct sequencing (right). On the l...
<p>B). <i>KRAS</i> mutated samples in NCT00890825 with concomitant mutations.</p
A subgroup of non-small cell lung cancer (NSCLC) cases harbour mutations in classical oncogenes, whi...
<p>For the digital PCR assay, signals from wild-type-specific probe are detected as blue, and signal...
<p>(a) The heterozygous p.E542K (c.G1624A) <i>PIK3CA</i> hotspot mutation was detected in sample no....
<p>Panel A: PIK3CA mutations (exon9: n = 643; exon20: n = 636). Panel B: NRAS mutations (codons12 & ...
<p>(A) Cy5 fluorescence signal corresponding to the mutated allele. (B) spotting scheme. wt: wild-ty...
PURPOSE: PIK3CA gene encoding a catalytic subunit of the phosphatidylinositol-3-kinase (PI3K) is mut...
The data in this article are related to the research article entitled “Optimization of melting analy...
Purpose: PIK3CA gene encoding a catalytic subunit of the phosphatidylinositol-3-kinase (PI3K) is mut...
Introduction: Although KRAS mutations in NSCLC have been considered mutually exclusive driver mutati...
Selection of NSCLC patients for targeted therapy is currently based upon the presence of sensitizing...
Selection of NSCLC patients for targeted therapy is currently based upon the presence of sensitizing...
<p>Dataset A, n = 22/58 (38.5%) AUC = 0.67, 95%CI: 0.5–0.8, p = 0.04), <b>B.</b> Dataset B n = 6/23 ...
Aims To evaluate the incidence of PI3KCA, KRAS and BRAF mutations in primary ovarian clear cell carc...
<p>A. Detection of mutations in PIK3CA by LightCycler (left) and direct sequencing (right). On the l...
<p>B). <i>KRAS</i> mutated samples in NCT00890825 with concomitant mutations.</p
A subgroup of non-small cell lung cancer (NSCLC) cases harbour mutations in classical oncogenes, whi...
<p>For the digital PCR assay, signals from wild-type-specific probe are detected as blue, and signal...
<p>(a) The heterozygous p.E542K (c.G1624A) <i>PIK3CA</i> hotspot mutation was detected in sample no....
<p>Panel A: PIK3CA mutations (exon9: n = 643; exon20: n = 636). Panel B: NRAS mutations (codons12 & ...
<p>(A) Cy5 fluorescence signal corresponding to the mutated allele. (B) spotting scheme. wt: wild-ty...
PURPOSE: PIK3CA gene encoding a catalytic subunit of the phosphatidylinositol-3-kinase (PI3K) is mut...
The data in this article are related to the research article entitled “Optimization of melting analy...
Purpose: PIK3CA gene encoding a catalytic subunit of the phosphatidylinositol-3-kinase (PI3K) is mut...
Introduction: Although KRAS mutations in NSCLC have been considered mutually exclusive driver mutati...
Selection of NSCLC patients for targeted therapy is currently based upon the presence of sensitizing...
Selection of NSCLC patients for targeted therapy is currently based upon the presence of sensitizing...
<p>Dataset A, n = 22/58 (38.5%) AUC = 0.67, 95%CI: 0.5–0.8, p = 0.04), <b>B.</b> Dataset B n = 6/23 ...
Aims To evaluate the incidence of PI3KCA, KRAS and BRAF mutations in primary ovarian clear cell carc...